Mr. Inas Said reports

CANADIAN SECURITIES EXCHANGE WELCOMES LISTING OF RISE NANO OPTICS LTD.

The Canadian Securities Exchange has welcomed the listing of Rise Nano Optics Ltd. The company, which is based in Haifa, Israel, had its common shares listed on the CSE on March 12, 2026, following the completion of a reverse takeover transaction. The ticker symbol is EYE.

Rise is a health technology company focused on harnessing nanotechnology to reduce vision stress and prevent eye disease. Its flagship Spectraguard lenses are designed to filter high-energy wavelengths from everyday surroundings and protect eyes against bright light. The company is working to launch its products in Canada and the United States this year.

"The Canadian Securities Exchange is always pleased to welcome entrepreneurs working to harness emerging technologies in innovative ways, and that is precisely what Rise Nano Optics is doing," said Stuart Schady, the CSE's vice-president, business development. "Rise also adds to the CSE's impressive lineup of Israeli firms, which now includes five companies."

"Today marks a defining moment in our company's journey. Our listing on the CSE reflects years of dedication, innovation and the unwavering belief of our team, partners and investors in the vision we set out to achieve," said Inas Said, chief executive officer of Rise Nano Optics. "Becoming a public company opens an exciting new chapter for us. With greater access to capital and a broader investor base, we are well positioned to accelerate our growth, expand our global presence and continue delivering innovative solutions while creating long-term value for our shareholders."